MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jiph.2025.102981

Медицинская библиотека · Journal of infection and public health · 2025

Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis.

Virseda-Berdices Ana, Requena Belen, Berenguer Juan, Gónzalez-García Juan, Gonzalez-Riano Carolina, Díez Cristina, Hontañón Victor, Muñoz-García Paula, Fernández-Rodríguez Amanda, Barbas Coral, Resino Salvador, Martín-Escolano Rubén, Jiménez-Sousa María Ángeles, Marathon Study Group

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Despite successful hepatitis C virus (HCV) clearance, some individuals continue to experience liver disease progression. Metabolic dysfunction-associated steatotic liver disease (MASLD) may play a key role in this ongoing progression. This study aims to characterize the lipidomic profiles associated with MASLD in individuals coinfected with human immunodeficiency virus (HIV) and HCV with advanced fibrosis or cirrhosis after sustained virologic response (SVR).

METHODS

We conducted cross-sectional studies in fifty-two HIV/HCV-coinfected individuals. Untargeted lipidomics was performed on plasma samples collected at 1 year and 6 years post-SVR using liquid chromatography-mass spectrometry. The primary outcome was MASLD. Statistical analyses included orthogonal partial least squares discriminant analysis (OPLS-DA) and generalized linear models (GLM), with corrections for multiple comparisons.

RESULTS

The prevalence of MASLD was 28.9 % one year after SVR, increasing to 44.8 % six years after SVR. OPLS-DA models identified 225 lipids at 1 year and 167 at 6 years, with a VIP score ≥ 1, distinguishing individuals based on MASLD status. Adjusted GLMs confirmed significant associations between MASLD and 116 lipids at 1 year and 49 at 6 years. At 1 year, most significant lipids were glycerophospholipids (GP), with increased phosphatidylcholines (PC) and phosphatidylethanolamines (PE), and decreased lysophosphatidylcholines (LPC) and lysophosphatidylethanolamines (LPE). By 6 years, LPC was the most abundant differential lipid, while triglycerides increased significantly.

CONCLUSIONS

MASLD was common during follow-up, with changes in lipidomic profiles over time suggesting ongoing metabolic disturbances that may contribute to liver disease progression despite SVR. These findings highlight the need for long-term metabolic and liver health monitoring after HCV eradication in these individuals.

Для цитирования: Virseda-Berdices Ana, Requena Belen, Berenguer Juan, Gónzalez-García Juan, Gonzalez-Riano Carolina, Díez Cristina, Hontañón Victor, Muñoz-García Paula, Fernández-Rodríguez Amanda, Barbas Coral, Resino Salvador, Martín-Escolano Rubén, Jiménez-Sousa María Ángeles, Marathon Study Group. Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis.. Journal of infection and public health. 2025. DOI: 10.1016/j.jiph.2025.102981.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.